Skip to content

Air Pollution Study: The Effect of Ozone on the Lung

Activated Macrophages and Ozone Toxicity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02673775
Enrollment
135
Registered
2016-02-04
Start date
2016-02-29
Completion date
2022-06-07
Last updated
2025-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Air Pollution

Keywords

Macrophage

Brief summary

The purpose of the study is to better understand the mechanisms of lung injury from ozone exposure. Subjects will participate in two exposure sessions: filtered air and 0.2 ppm ozone. Subjects will be asked to produce sputum through coughing after each exposure. The samples will be analyzed for macrophage activity.

Detailed description

Subjects will be asked to come to the Rutgers EOHSI clinical center (Piscataway, NJ) for 5 study visits. A physical exam to determine eligibility will be done at the first study visit. If the subject is healthy and able to produce a sputum sample, he/she will then be scheduled for 2 3-hour exposure visits. One exposure will be to clean air and the other exposure will be to 0.2 ppm ozone. During the exposures, subjects will be requested to ride an exercise bicycle intermittently (approximately every 15 minutes). A follow-up visit for sputum collection will be scheduled either 24, 48, or 72 hours after each exposure visit. Blood, urine, and exhaled breath samples will also be collected at each visit.

Interventions

Subjects will have the clean air exposure first, followed by the ozone exposure

OTHEROzone

Subjects will have the ozone exposure first, followed by the clean air exposure

Sponsors

National Institute of Environmental Health Sciences (NIEHS)
CollaboratorNIH
Rutgers, The State University of New Jersey
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy men and women

Exclusion criteria

* Cardiovascular disease * Respiratory disease * Diabetes * Pregnancy * HIV infection * History of smoking within the last 5 years * Daily use of antioxidant supplements (e.g., Vitamin C/E, selenium, beta-carotene, lycopene, lutein, zeaxanthin, or ginkgo biloba) * Orthopedic or rheumatological conditions that would interfere with cycle use

Design outcomes

Primary

MeasureTime frameDescription
Concentrations of M1 and M2 Macrophages in the Sputum 24 Hours After Exposure.24 hours after exposure.The relative concentrations of M1 and M2 macrophages in the induced sputum sample will be assessed.
Concentrations of M1 and M2 Macrophages in the Sputum 48 Hours After Exposure.48 hours after exposureThe relative concentrations of M1 and M2 macrophages in the induced sputum sample will be assessed.
Concentrations of M1 and M2 Macrophages in the Sputum 72 Hours After Exposure.72 hours after exposure.Relative concentrations of M1 and M2 macrophages in the induced sputum sample will be assessed.

Countries

United States

Participant flow

Recruitment details

135 participants from the local community were screened for eligibility between 2/1/2016 and 5/4/2022.

Pre-assignment details

57 were ineligible and 16 were lost to follow-up. 62 were randomized to the first exposure.

Participants by arm

ArmCount
Overall
All participants who were randomized to a first exposure (N=62)
62
Total62

Withdrawals & dropouts

PeriodReasonFG000FG001
Washout (at Least 2 Weeks)Lost to Follow-up10
Washout (at Least 2 Weeks)Physician Decision10
Washout (at Least 2 Weeks)Study paused during COVID pandemic (3/5/2020 to 9/15/2021)22
Washout (at Least 2 Weeks)Withdrawal by Subject02

Baseline characteristics

CharacteristicOverall
Age, Continuous23.2 years
STANDARD_DEVIATION 4.8
Ethnicity (NIH/OMB)
Hispanic or Latino
14 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
48 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
21 Participants
Race (NIH/OMB)
Black or African American
6 Participants
Race (NIH/OMB)
More than one race
2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
Race (NIH/OMB)
White
30 Participants
Sex: Female, Male
Female
36 Participants
Sex: Female, Male
Male
26 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 580 / 58
other
Total, other adverse events
0 / 580 / 58
serious
Total, serious adverse events
0 / 580 / 58

Outcome results

Primary

Concentrations of M1 and M2 Macrophages in the Sputum 24 Hours After Exposure.

The relative concentrations of M1 and M2 macrophages in the induced sputum sample will be assessed.

Time frame: 24 hours after exposure.

Population: The number of participants who had an adequate sputum sample collected 24 hours after each exposure.

ArmMeasureValue (MEAN)Dispersion
Clean AirConcentrations of M1 and M2 Macrophages in the Sputum 24 Hours After Exposure.6.823 ratio of M2 to M1 macrophagesStandard Error 2.413
OzoneConcentrations of M1 and M2 Macrophages in the Sputum 24 Hours After Exposure.1.367 ratio of M2 to M1 macrophagesStandard Error 0.367
Primary

Concentrations of M1 and M2 Macrophages in the Sputum 48 Hours After Exposure.

The relative concentrations of M1 and M2 macrophages in the induced sputum sample will be assessed.

Time frame: 48 hours after exposure

Population: The number of participants who had an adequate sputum sample collected 48 hours after each exposure.

ArmMeasureValue (MEAN)Dispersion
Clean AirConcentrations of M1 and M2 Macrophages in the Sputum 48 Hours After Exposure.9.783 ratio of M2 to M1 macrophagesStandard Error 3.239
OzoneConcentrations of M1 and M2 Macrophages in the Sputum 48 Hours After Exposure.3.449 ratio of M2 to M1 macrophagesStandard Error 1.116
Primary

Concentrations of M1 and M2 Macrophages in the Sputum 72 Hours After Exposure.

Relative concentrations of M1 and M2 macrophages in the induced sputum sample will be assessed.

Time frame: 72 hours after exposure.

Population: The number of participants who had an adequate sputum sample collected 72 hours after each exposure.

ArmMeasureValue (MEAN)Dispersion
Clean AirConcentrations of M1 and M2 Macrophages in the Sputum 72 Hours After Exposure.4.623 ratio of M2 to M1 macrophagesStandard Error 0.782
OzoneConcentrations of M1 and M2 Macrophages in the Sputum 72 Hours After Exposure.4.379 ratio of M2 to M1 macrophagesStandard Error 0.623

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026